{"id":"https://openalex.org/W2260219609","doi":"https://doi.org/10.1200/jco.2006.24.18_suppl.7065","title":"Prospective FDG-PET and CT assessment of discontinuation of erlotinib (E) or gefitinib (G) in patients with EGFR TKI sensitive non-small cell lung cancer (NSCLC) who subsequently progress radiographically on E or G (\u201cacquired resistance\u201d) followed by re-initiation of E or G and the subsequent addition of everolimus (RAD001)","display_name":"Prospective FDG-PET and CT assessment of discontinuation of erlotinib (E) or gefitinib (G) in patients with EGFR TKI sensitive non-small cell lung cancer (NSCLC) who subsequently progress radiographically on E or G (\u201cacquired resistance\u201d) followed by re-initiation of E or G and the subsequent addition of everolimus (RAD001)","publication_year":2006,"publication_date":"2006-06-20","ids":{"openalex":"https://openalex.org/W2260219609","doi":"https://doi.org/10.1200/jco.2006.24.18_suppl.7065","mag":"2260219609"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2006.24.18_suppl.7065","doi":"https://doi.org/10.1200/jco.2006.24.18_suppl.7065","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2006.24.18_suppl.7065","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060033755","display_name":"Gregory J. Riely","orcid":"https://orcid.org/0000-0001-5357-4313","observed_orcids":["https://orcid.org/0000-0001-5357-4313"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G. J. Riely","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039791495","display_name":"Mark G. Kris","orcid":"https://orcid.org/0000-0002-7317-5341","observed_orcids":["https://orcid.org/0000-0002-7317-5341"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. G. Kris","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058825770","display_name":"Lawrence Howard Schwartz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L. H. Schwartz","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108457775","display_name":"Timothy Akhurst","orcid":"https://orcid.org/0000-0002-6521-4312","observed_orcids":["https://orcid.org/0000-0002-6521-4312"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T. Akhurst","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111996693","display_name":"Binsheng Zhao","orcid":"https://orcid.org/0009-0009-9934-9141","observed_orcids":["https://orcid.org/0009-0009-9934-9141","https://orcid.org/0000-0001-9212-0293"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B. Zhao","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046345302","display_name":"Daniel T. Milton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. T. Milton","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042226261","display_name":"Erin Moore","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. Moore","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108547154","display_name":"Leslie B. Tyson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L. Tyson","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062616992","display_name":"William J. Pao","orcid":"https://orcid.org/0000-0002-9888-0733","observed_orcids":["https://orcid.org/0000-0002-9888-0733"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W. Pao","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111548816","display_name":"V.A. Miller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"V. A. Miller","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1334819555"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"24","issue":"18_suppl","first_page":"7065","last_page":"7065"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9409999847412109},{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.9679999947547913},{"id":"https://openalex.org/keywords/erlotinib","display_name":"erlotinib","score":0.9480000138282776},{"id":"https://openalex.org/keywords/gefitinib","display_name":"gefitinib","score":1.0},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.9449999928474426},{"id":"https://openalex.org/keywords/everolimus","display_name":"everolimus","score":0.8820000290870667},{"id":"https://openalex.org/keywords/mtor-inhibition","display_name":"mTOR inhibition","score":0.878000020980835},{"id":"https://openalex.org/keywords/egfr-mutation","display_name":"EGFR mutation","score":0.7739999890327454},{"id":"https://openalex.org/keywords/fdg-pet-ct","display_name":"FDG PET/CT","score":0.7820000052452087},{"id":"https://openalex.org/keywords/standardized-uptake-value","display_name":"standardized uptake value","score":0.9190000295639038},{"id":"https://openalex.org/keywords/tumor-metabolism","display_name":"cancer metabolism","score":0.625},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.5870000123977661},{"id":"https://openalex.org/keywords/radiographic-progression","display_name":"radiographic progression","score":0.7210000157356262},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6179999709129333},{"id":"https://openalex.org/keywords/stage-iv-lung-cancer","display_name":"stage IV lung cancer","score":0.640999972820282},{"id":"https://openalex.org/keywords/tumor-volume-change","display_name":"tumor volume change","score":0.3070000112056732},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.5080000162124634}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9424090385437012},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.8384506702423096},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.7351325750350952},{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.7320517301559448},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5484536290168762},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5266910791397095},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.42537909746170044},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3889160454273224},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.3726643919944763},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.3118841052055359}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2006.24.18_suppl.7065","doi":"https://doi.org/10.1200/jco.2006.24.18_suppl.7065","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2006.24.18_suppl.7065","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2142865455","https://openalex.org/W3012119175","https://openalex.org/W2591559970","https://openalex.org/W1994508061","https://openalex.org/W653507833","https://openalex.org/W1715002034","https://openalex.org/W2075966944","https://openalex.org/W2543014352","https://openalex.org/W2598754179","https://openalex.org/W2597724245"],"abstract_inverted_index":{"7065":[0],"Background:":[1],"About":[2],"10%":[3],"of":[4,49,75,80,88,128,146,202,204,209,220,228,240,245,252,258,263,269,300,315,327],"patients":[5,51,55,293],"(pts)":[6],"with":[7,56,99,103,116,163,189,350],"NSCLC":[8,102],"have":[9,187],"a":[10],"radiographic":[11,112,122],"response":[12,113],"to":[13,30,43,61,93,285,338],"E":[14,44,76,81,94,117,147,154,169,205,241,259,286,301,328,351,362],"or":[15,45,77,82,95,106,110,118,148,155,170,206,242,260,287,302,329,352,363],"G.":[16,46,96,171,243,261,288,353],"A":[17],"dependence":[18],"on":[19,182,185,313,325,355],"signaling":[20],"through":[21],"the":[22,86,89],"epidermal":[23],"growth":[24],"factor":[25],"receptor":[26],"(EGFR)":[27],"is":[28,52],"thought":[29],"underlie":[31],"this":[32],"response.":[33],"Despite":[34],"initial":[35],"regression,":[36],"these":[37,50,356],"pts":[38,133,180,191,222,247,265],"invariably":[39],"develop":[40,295],"acquired":[41,57,296],"resistance":[42],"Optimal":[47],"management":[48],"unknown.":[53],"In":[54,290],"resistance,":[58],"we":[59,358],"sought":[60],"evaluate":[62],"changes":[63],"in":[64,226,232,250,276,305,311,365],"tumor":[65,334],"metabolism":[66],"by":[67,71],"PET":[68,314],"and":[69,84,120,137,157,168,196,230,273,309,321],"size":[70],"CT":[72,139,172,197,233,277],"after":[73,114,124,144,152,160,238,256,281],"discontinuation":[74,145,203,239],"G,":[78,83,149,156,183,207,330],"resumption":[79,257],"then":[85,121],"addition":[87],"mTOR":[90],"inhibitor":[91],"everolimus":[92,164,282,347],"Methods:":[97],"Pts":[98],"stage":[100],"IV":[101],"exon":[104],"19":[105],"21":[107],"EGFR":[108,291,339],"mutation":[109],"previous":[111],"treatment":[115,129,162],"G":[119,303,364],"progression":[123,308],">":[125,271],"6":[126,190,221,246,264],"months":[127],"were":[130,174],"eligible.":[131],"All":[132],"had":[134,223,248,266],"4":[135,184,194],"FDG-PET/CT":[136],"helical":[138],"scans:":[140],"baseline,":[141],"3":[142,150,158,200,236,254,279],"weeks":[143,151,159,201,237,255,280],"restarting":[153],"combined":[161,349],"(5":[165,181],"mg":[166],"daily)":[167],"measurements":[173,234,278],"uni-dimensional.":[175],"Results:":[176],"To":[177],"date,":[178],"9":[179,210],"E)":[186],"enrolled":[188],"completing":[192],"all":[193],"PET/CT":[195],"assessments.":[198],"Within":[199],"7":[208],"(77%,":[211],"95%":[212],"CI":[213],"40\u201397%)":[214],"developed":[215],"symptomatic":[216,307],"disease":[217],"progression.":[218],"Three":[219,244],"an":[224],"increase":[225,231],"SUV":[227,251,270,312,322],">50%":[229],">15%":[235],"decrease":[249,275],">10%":[253,274],"Two":[262],"further":[267,344],"reduction":[268],"50%":[272],"was":[283,348],"added":[284],"Conclusions:":[289],"TKI-sensitive":[292],"who":[294],"resistance:":[297],"1)":[298],"Discontinuation":[299],"results":[304],"rapid":[306],"increases":[310],"indicator":[316],"lesions.":[317],"2)":[318],"Both":[319],"symptoms":[320],"values":[323],"improve":[324],"re-initiation":[326],"suggesting":[331],"that":[332],"some":[333],"cells":[335],"remain":[336],"sensitive":[337],"blockade.":[340],"3)":[341],"We":[342],"saw":[343],"improvement":[345],"when":[346],"Based":[354],"data":[357],"now":[359],"recommend":[360],"continuing":[361],"similar":[366],"patients.":[367],"Support:":[368],"Novartis,":[369],"CA05826,":[370],"MSKCC":[371],"\u201cSteps":[372],"for":[373],"Breath.\u201d":[374],"[Table:":[375],"see":[376],"text]":[377]},"counts_by_year":[],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2016-06-24T00:00:00"}